Viyash Scientific Ltd EPS

Viyash Scientific Ltd EPS

Image

Viyash Scientific Ltd

NSE: VIYASH

EPS

₹ 2.99

Last updated on: Apr 30, 2026

Key Highlights

  • The Earning per Share of Viyash Scientific Ltd is ₹ 2.99 as of 30 Apr 26 The earning per share of Viyash Scientific Ltd changed from ₹ 0.26 to ₹ 0.89 over 7 quarters. This represents a CAGR of 102.01% .

Historical Earning per Share of Viyash Scientific Ltd

No data available

* All values are in

Company Fundamentals for Viyash Scientific Ltd

Market Cap

8,918 Cr

EPS

3.0

P/E Ratio (TTM)

68.3

P/B Ratio (TTM)

10.5

Day’s High

207.0

Day’s Low

203.3

DTE

0.6

ROE

15.2

52 Week High

260.3

52 Week Low

141.8

ROCE

18.2

Market Price of Viyash Scientific Ltd

1M

1Y

3Y

5Y

Monitoring Viyash Scientific Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Apr 2026204.15
29 Apr 2026207.3
28 Apr 2026210.05
27 Apr 2026208.8
24 Apr 2026206.6
23 Apr 2026211.9
22 Apr 2026209.6
21 Apr 2026208.35
20 Apr 2026207.3
17 Apr 2026208.9

SWOT Analysis Of Viyash Scientific Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Viyash Scientific Ltd

Asset Value vs Market Value of Viyash Scientific Ltd

Market Value

8,919

Asset Value

Value addition

8.1 X

977

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Viyash Scientific Ltd8918
Sun Pharmaceutical Industries Ltd433848
Divis Laboratories Ltd172697
Torrent Pharmaceuticals Ltd141859
Dr Reddys Laboratories Ltd110421
Cipla Ltd105811

Historical Market Cap of Viyash Scientific Ltd

No data available

* All values are in crore

Historical Revenue of Viyash Scientific Ltd

No data available

* All values are in crore

Historical EBITDA of Viyash Scientific Ltd

No data available

* All values are in crore

Historical Net Profit of Viyash Scientific Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Viyash Scientific Ltd News Hub

Sequent Scientific receives WHO prequalification approval for Albendazole API

Sequent Scientific announced its receipt of prequalification (PQ) approval from the World Health Org

Read more

20 Aug 24

Sequent Scientific hits 52-week high after receiving prequalification approval for Albendazole

This is in partnership with Mepro Pharmaceuticals, who have successfully developed and commercialise

Read more

20 Aug 24

Sequent Scientific reports consolidated net profit of Rs 6.51 crore in the June 2024 quarter

Net profit of Sequent Scientific reported to Rs 6.51 crore in the quarter ended June 2024 as against

Read more

16 Aug 24

Sequent Scientific to table results

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 14 August 2024. P

Read more

09 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Viyash Scientific Ltd

What is the EPS of Viyash Scientific Ltd stock?

The Earnings Per Share (EPS) of Viyash Scientific Ltd is 2.99. An EPS is the amount of net income attributed to each share of a common stock.

How is Viyash Scientific Ltd EPS calculated?

The EPS of Viyash Scientific Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Viyash Scientific Ltd report its EPS?

Viyash Scientific Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Viyash Scientific Ltd EPS?

Factors that influence the EPS of Viyash Scientific Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Viyash Scientific Ltd EPS growth indicate future performance?

Yes, consistent growth in Viyash Scientific Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions